Darya-Varia Laboratoria Tbk PT
IDX:DVLA

Watchlist Manager
Darya-Varia Laboratoria Tbk PT Logo
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Watchlist
Price: 1 615 IDR -0.31% Market Closed
Market Cap: 1.8T IDR
Have any thoughts about
Darya-Varia Laboratoria Tbk PT?
Write Note

Darya-Varia Laboratoria Tbk PT
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Darya-Varia Laboratoria Tbk PT
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Long-Term Investments
Rp37.9B
CAGR 3-Years
-22%
CAGR 5-Years
-18%
CAGR 10-Years
24%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Long-Term Investments
Rp45.5B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
-5%
Kalbe Farma Tbk PT
IDX:KLBF
Long-Term Investments
Rp455.8B
CAGR 3-Years
16%
CAGR 5-Years
39%
CAGR 10-Years
27%
Soho Global Health Tbk PT
IDX:SOHO
Long-Term Investments
Rp3.9B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Long-Term Investments
Rp99.7B
CAGR 3-Years
57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Long-Term Investments
Rp1.1T
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
21%
No Stocks Found

Darya-Varia Laboratoria Tbk PT
Glance View

Market Cap
1.8T IDR
Industry
Pharmaceuticals

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,274 full-time employees. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The firm provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The firm also provides Imunped as supplement for kids with Zinc and vitamin C for children.

DVLA Intrinsic Value
2 170.57 IDR
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Darya-Varia Laboratoria Tbk PT's Long-Term Investments?
Long-Term Investments
37.9B IDR

Based on the financial report for Sep 30, 2024, Darya-Varia Laboratoria Tbk PT's Long-Term Investments amounts to 37.9B IDR.

What is Darya-Varia Laboratoria Tbk PT's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
24%

Over the last year, the Long-Term Investments growth was -6%. The average annual Long-Term Investments growth rates for Darya-Varia Laboratoria Tbk PT have been -22% over the past three years , -18% over the past five years , and 24% over the past ten years .

Back to Top